-
1دورية أكاديمية
المؤلفون: Rao, Sunil V, Kirsch, Bodo, Bhatt, Deepak L, Budaj, Andrzej, Coppolecchia, Rosa, Eikelboom, John, James, Stefan K, Jones, W Schuyler, Merkely, Bela, Keller, Lars, Hermanides, Renicus S, Campo, Gianluca, Ferreiro, José Luis, Shibasaki, Taro, Mundl, Hardi, Alexander, John H
المساهمون: Rao, Sunil V, Kirsch, Bodo, Bhatt, Deepak L, Budaj, Andrzej, Coppolecchia, Rosa, Eikelboom, John, James, Stefan K, Jones, W Schuyler, Merkely, Bela, Keller, Lar, Hermanides, Renicus S, Campo, Gianluca, Ferreiro, José Lui, Shibasaki, Taro, Mundl, Hardi, Alexander, John H
مصطلحات موضوعية: anticoagulants, myocardial infarction, factor XIa
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36030390; info:eu-repo/semantics/altIdentifier/wos/WOS:000868828600005; volume:146; issue:16; firstpage:1196; lastpage:1206; numberofpages:11; journal:CIRCULATION; https://hdl.handle.net/11392/2520330Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85139497397
الإتاحة: https://doi.org/10.1161/CIRCULATIONAHA.122.061612Test
https://hdl.handle.net/11392/2520330Test -
2
المؤلفون: Urban, Philip, Mehran, Roxana, Colleran, Roisin, Angiolillo, Dominick J, Byrne, Robert A, Capodanno, Davide, Cuisset, Thomas, Cutlip, Donald, Eerdmans, Pedro, Eikelboom, John, Farb, Andrew, Gibson, C Michael, Gregson, John, Haude, Michael, James, Stefan K, Kim, Hyo-Soo, Kimura, Takeshi, Konishi, Akihide, Laschinger, John, Leon, Martin B, Magee, PF Adrian, Mitsutake, Yoshiaki, Mylotte, Darren, Pocock, Stuart, Price, Matthew J, Rao, Sunil V, Spitzer, Ernest, Stockbridge, Norman, Valgimigli, Marco, Varenne, Olivier, Windhoevel, Ute, Yeh, Robert W, Krucoff, Mitchell W, Morice, Marie-Claude
المساهمون: Hôpital de la Tour, Cardiovascular Research Foundation, Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), University of Florida [Gainesville] (UF), University of Catania [Italy], Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Beth Israel Deaconess Medical Center [Boston] (BIDMC), Harvard Medical School [Boston] (HMS), AUTRES, McMaster University [Hamilton, Ontario], U.S. Food and Drug Administration (FDA), Beth Israel Deaconess Medical Center [Boston, USA], London School of Hygiene and Tropical Medicine (LSHTM), Lukaskrankenhaus, Uppsala University, Seoul National University Hospital, Kyoto University [Kyoto], Pharmaceuticals and Medical Devices Agency, Columbia University Medical Center (CUMC), Columbia University [New York], National University of Ireland [Galway] (NUI Galway), Scripps Clinic [San Diego, CA, USA], Duke Clinical Research Institute, Erasmus University Medical Center [Rotterdam] (Erasmus MC), University of Bern, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Cardiovascular European Research Center, Hôpital Privé Jacques Cartier [Massy], Abbott Vascular, Alvimedica, Amgen, AstraZeneca, Biosensors, Biotronik, Boston Scientific, Celonova, Chiesi, Cordis, Daiichi Sankyo, Edwards Lifesciences, Janssen, Medinol, Medtronic, Orbusneich, Portola, Sanofi, Sinomed, Sahajanand Medical Technologies, and Terumo., Cardiology, Kyoto University, Prémilleux, Annick
المصدر: Circulation
Circulation, American Heart Association, 2019, 140 (3), pp.240-261. ⟨10.1161/CIRCULATIONAHA.119.040167⟩
Circulation, 140(3), 240-261. Lippincott Williams & Wilkins
Circulation, 2019, 140 (3), pp.240-261. ⟨10.1161/CIRCULATIONAHA.119.040167⟩مصطلحات موضوعية: Paris, Consensus, [SDV]Life Sciences [q-bio], percutaneous coronary intervention, White Paper, Anticoagulants, Congresses as Topic, Risk Assessment, State of the Art, [SDV] Life Sciences [q-bio], District of Columbia, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, Humans, clinical trial protocols as topic, hemorrhage
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d093dfd95ca7f7acc956bc75808aaff4Test
https://hal-amu.archives-ouvertes.fr/hal-02542119/documentTest -
3دورية أكاديمية
المؤلفون: Steg, Philippe Gabriel, Huber, Kurt, Andreotti, Felicita, Arnesen, Harald, Atar, Dan, Badimon, Lina, Bassand, Jean-Pierre, De Caterina, Raffaele, Eikelboom, John A, Gulba, Dietrich, Hamon, Martial, Helft, Gérard, Fox, Keith A A, Kristensen, Steen D, Rao, Sunil V, Verheugt, Freek W A, Widimsky, Petr, Zeymer, Uwe, Collet, Jean-Philippe
المصدر: Steg , P G , Huber , K , Andreotti , F , Arnesen , H , Atar , D , Badimon , L , Bassand , J-P , De Caterina , R , Eikelboom , J A , Gulba , D , Hamon , M , Helft , G , Fox , K A A , Kristensen , S D , Rao , S V , Verheugt , F W A , Widimsky , P , Zeymer , U & Collet , J-P 2011 , ' Bleeding in acute coronary syndromes and percutaneous coronary interventions : position paper ....
مصطلحات موضوعية: Acute Coronary Syndrome, Angioplasty, Balloon, Coronary, Anticoagulants, Blood Transfusion, Catheters, Indwelling, Drug Dosage Calculations, Female, Fibrinolytic Agents, Gastrointestinal Hemorrhage, Hemorrhage, Humans, Kidney Diseases, Male, Practice Guidelines as Topic, Prognosis, Randomized Controlled Trials as Topic, Risk Factors, Sex Factors, Thrombosis
الإتاحة: https://doi.org/10.1093/eurheartj/ehr204Test
https://pure.au.dk/portal/en/publications/3120a8d4-f7fb-493e-83a0-0b324c9e2a11Test -
4دورية أكاديمية
المؤلفون: Steg, Philippe Gabriel, Mehta, Shamir R., Pollack Jr, Charles V., Bode, Christoph, Cohen, Marc, French, William J., Hoekstra, James, Rao, Sunil V., Ruzyllo, Witold, Ruiz-Nodar, Juan M., Sabaté, Manel, Widimsky, Petr, Kiss, Robert Gabor, Navarro Estrada, Jose Luis, Hod, Hanoch, Kerkar, Prafulla, Guneri, Sema, Sezer, Murat, Ruda, Mikhail, Nicolau, José Carlos
المصدر: JAMA: Journal of the American Medical Association; 9/18/2013, Vol. 310 Issue 11, p1145-1155, 11p
مصطلحات موضوعية: TREATMENT of acute coronary syndrome, ANTICOAGULANTS, DRUG efficacy, HEPARIN, EPTIFIBATIDE, CARDIOVASCULAR disease treatment, THROMBOSIS, THERAPEUTICS
-
5دورية أكاديمية
المؤلفون: Van De Car, David A., Rao, Sunil V., Ohman, E. Magnus
المصدر: Expert Review of Cardiovascular Therapy; Dec2010, Vol. 8 Issue 12, p1673-1681, 9p
مصطلحات موضوعية: PHARMACOLOGY, ANTITHROMBINS, CARDIOVASCULAR agents, ANTICOAGULANTS, ENDOVASCULAR surgery, ACUTE coronary syndrome, HEPARIN, THROMBOCYTOPENIA
-
6دورية أكاديمية
المؤلفون: Bertrand, Olivier F., Rao, Sunil V., Pancholy, Samir, Jolly, Sanjit S., Rodés-Cabau, Josep, Larose, Éric, Costerousse, Olivier, Hamon, Martial, Mann, Tift
المصدر: JACC: Cardiovascular Interventions; Oct2010, Vol. 3 Issue 10, p1022-1031, 10p
مصطلحات موضوعية: ANGIOPLASTY, CARDIOLOGISTS, ARTERIAL catheterization, QUESTIONNAIRES, ANTICOAGULANTS, HOSPITAL admission & discharge
-
7دورية أكاديمية
المؤلفون: Steg, Philippe Gabriel, Jolly, Sanjit S., Mehta, Shamir R., Afzal, Rizwan, Xavier, Dennis, Rupprecht, Hans-Jurgen, López-Sendón, Jose L., Budaj, Andrzej, Diaz, Rafael, Avezum, Álvaro, Widimsky, Petr, Rao, Sunil V., Chrolavicius, Susan, Meeks, Brandi, Joyner, Campbell, Pogue, Janice, Yusuf, Salim
المصدر: JAMA: Journal of the American Medical Association; 9/22/2010, Vol. 304 Issue 12, p1339-1349, 11p, 1 Diagram, 3 Charts, 3 Graphs
مصطلحات موضوعية: HEPARIN, CARDIAC patients, CLINICAL drug trials, CORONARY heart disease treatment, DRUG dosage, ANTICOAGULANTS
-
8دورية أكاديمية
المؤلفون: Rao, Sunil V., Ohman, E. Magnus
المصدر: Circulation: Cardiovascular Interventions; Feb2010, Vol. 3 Issue 1, p80-88, 9p, 1 Chart, 3 Graphs
مصطلحات موضوعية: ANTICOAGULANTS, PHARMACOKINETICS, PHARMACODYNAMICS, DISEASE complications, IATROGENIC diseases
-
9دورية أكاديمية
المؤلفون: Rao, Sunil V.1 sunil.rao@duke.edu, Mehran, Roxana1
المصدر: Circulation. 3/20/2012, Vol. 125 Issue 11, p1344-1346. 3p.
مصطلحات موضوعية: *HEMORRHAGE, *PATIENTS, *MORTALITY, *ANGIOPLASTY
-
10دورية أكاديمية
المؤلفون: Rao, Sunil V.1 sunil.rao@duke.edu
المصدر: American Journal of Cardiology. Sep2009 Supplement, Vol. 104 Issue 5, p60C-63C. 0p.
مصطلحات موضوعية: *CORONARY disease, *ANTICOAGULANTS, *ANGIOPLASTY, *ASPIRIN, *HEMORRHAGE risk factors, *HEALTH outcome assessment, *CORONARY artery bypass, *PATIENTS